Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Carl Icahn's Portfolio
|Company||Ticker||# of Shares||Change||Price||Value|
|ICAHN ENT DEP UTS||IEP||105,842,442||+2,984,791||$113.44||$12,006,766,621||History »||Related Stories »|
|Apple, Inc.||AAPL||52,760,848||+45,223,584||$102.13||$5,388,465,407||History »||Related Stories »|
|CVR Energy||CVI||71,198,718||$49.13||$3,497,993,016||History »||Related Stories »|
|Federal-Mogul Corporation||FDML||121,111,976||$16.86||$2,041,947,916||History »||Related Stories »|
|Chesapeake Energy Corp.||CHK||66,450,000||$26.43||$1,756,273,500||History »||Related Stories »|
|eBay, Inc.||EBAY||30,803,015||+3,000,000||$55.92||$1,722,504,599||History »||Related Stories »|
|Hertz Global Holdings||HTZ||38,800,000||+38,800,000||$30.74||$1,192,712,000||History »||Related Stories »|
|Nuance Communications, Inc.||NUAN||60,784,623||$17.03||$1,035,162,130||History »||Related Stories »|
|Herbalife||HLF||17,000,000||$51.09||$868,530,000||History »||Related Stories »|
|Hologic, Inc.||HOLX||34,154,879||$24.98||$853,188,878||History »||Related Stories »|
|NetFlix, Inc.||NFLX||1,764,907||-479,692||$474.70||$837,801,353||History »||Related Stories »|
|Transocean||RIG||21,477,900||$38.59||$828,832,161||History »||Related Stories »|
|Talisman Energy, Inc.||TLM||76,060,078||$10.24||$778,855,199||History »||Related Stories »|
|Navistar International||NAV||14,337,524||+1,027,789||$38.00||$544,825,912||History »||Related Stories »|
|Gannett Co., Inc.||GCI||14,967,373||+12,232,485||$33.83||$506,346,229||History »||Related Stories »|
|FreightCar America, Inc.||RAIL||11,871,268||$29.97||$355,781,902||History »||Related Stories »|
|Mentor Graphics Corp||MENT||16,120,289||$21.57||$347,714,634||History »||Related Stories »|
|Family Dollar Stores, Inc.||FDO||4,115,545||-2,753,487||$79.80||$328,420,491||History »||Related Stories »|
|CVR Refining||CVRR||6,000,000||$24.23||$145,380,000||History »||Related Stories »|
|Enzon Pharmaceuticals, Inc.||ENZN||5,904,863||$1.46||$8,621,100||History »||Related Stories »|
|VOLTARI||VLTC||678,203||$1.71||$1,159,728||History »||Related Stories »|
|Forest Laboratories, Inc.||FRX||Liquidated||History »||Related Stories »|